(Q33739366)

29 July 2017

1 reference

title

Quasispecies in viral persistence and pathogenesis of hepatitis C virus (English)

1 reference

29 July 2017

0 references

0 references

1 reference

1 reference

1 reference

2

Purcell RH

1 reference

29 July 2017

Forns X

1

1 reference

PubMed ID

10498948

29 July 2017

Bukh J

series ordinal

3

1 reference

29 July 2017

1 October 1999

1 reference

29 July 2017

Trends in Microbiology

1 reference

29 July 2017

7

1 reference

29 July 2017

10

1 reference

29 July 2017

402-410

1 reference

Hepatitis C: the clinical spectrum of disease

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Histopathological aspects of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

On the nature of virus quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hepatitis C viral quasispecies

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hypervariable regions in the putative glycoprotein of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Virus 'quasispecies': making a mountain out of a molehill?

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Quasispecies and the implications for virus persistence and escape

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Rapid evolution of RNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The quasispecies of hepatitis C virus and the host immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

1 reference

7 January 2021

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Immunological aspects of HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The role of immune responses in the pathogenesis of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Factors predictive of a beneficial response to therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Interferons in host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Interferon as treatment for acute hepatitis C. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Immunity in hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

Long-term outcome of hepatitis C infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0966-842X%2899%2901590-5

7 January 2021

10.1016/S0966-842X(99)01590-5

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10498948